# Transmural Systems Transcaval Closure Device for Transcaval Access Ports During Transcatheter Aortic Valve Replacement

> **NCT03432494** · NA · TERMINATED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 12 (actual)

## Conditions studied

- Aortic Stenosis

## Interventions

- **DEVICE:** Transcaval closure device (TCD)

## Key facts

- **NCT ID:** NCT03432494
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-02-07
- **Primary completion:** 2018-04-30
- **Final completion:** 2019-04-29
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** The trial was kept open (via administrative hold) in anticipation of a device redesign and enrollment suspended, but funding never materialized to support the redesign.
- **Last updated:** 2023-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03432494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03432494, "Transmural Systems Transcaval Closure Device for Transcaval Access Ports During Transcatheter Aortic Valve Replacement". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT03432494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*